Shares of BriaCell Therapeutics Corp. (OTCMKTS:BCTXF – Get Free Report) shot up 11% during mid-day trading on Friday . The company traded as high as $9.82 and last traded at $6.03. 40,713,650 shares were traded during trading, an increase of 2,189,983% from the average session volume of 1,859 shares. The stock had previously closed at $5.43.
BriaCell Therapeutics Trading Down 13.8 %
The firm has a 50 day moving average price of $4.07 and a 200 day moving average price of $2.24. The stock has a market capitalization of $4.01 million, a PE ratio of -0.01 and a beta of 1.09.
About BriaCell Therapeutics
BriaCell Therapeutics Corp. operates as a clinical-stage biotechnology company that specializes in immunotherapy for advanced breast cancer. It is advancing its targeted immunotherapy program by conducting a Phase I/IIA clinical trial with Bria-IMT in combination with an immune checkpoint inhibitor and a companion diagnostic test, BriaDx, to identify patients to benefit from Bria-IMT.
Featured Articles
- Five stocks we like better than BriaCell Therapeutics
- What Does a Stock Split Mean?
- O’Reilly Automotive: An Anytime Buy for Buy-and-Hold Investors
- Stock Dividend Cuts Happen Are You Ready?
- Chipotle Mexican Grill Serves Smoking Hot Entry Point in Q2
- Transportation Stocks Investing
- Markets Think Robinhood Earnings Could Send the Stock Up
Receive News & Ratings for BriaCell Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BriaCell Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
